RULE NO.:RULE TITLE:
64B8-9.012Standards for the Prescription of Obesity Drugs
PURPOSE AND EFFECT: The purpose of the rule development is to update the rule language.
SUBJECT AREA TO BE ADDRESSED: The rule language.
RULEMAKING AUTHORITY: 458.336 FS.
LAW IMPLEMENTED: 458.336 FS.
A RULE DEVELOPMENT WORKSHOP WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
DATE AND TIME: Thursday, August 5, 2021, 3:00 p.m., or as soon thereafter as can be heard.
PLACE: Embassy Suites Lake Buena Vista South, 4955 Kyngs Heath Road, Kissimmee, FL 34746.
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least five days before the workshop/meeting by contacting: Crystal Sanford, CPM, Program Operations Administrator, 4052 Bald Cypress Way, #C03, Tallahassee, FL 32399-3256, Crystal.Sanford@flhealth.gov. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Paul Vazquez, J.D., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253, Paul.Vazquez@flhealth.gov.
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.
Document Information
- Purpose:
- The purpose of the rule development is to update the rule language.
- Rulemaking Authority:
- 458.336 FS.
- Law:
- 458.336 FS.
- Related Rules: (1)
- 64B8-9.012. Standards for the Prescription of Obesity Drugs